Use of direct antiviral agents in liver transplant recipients with hepatitis C virus in Korea: 2-center experience.
Jong Man KimKwang-Woong LeeDong-Hyun SinnGyu-Seong ChoiNam-Joon YiChoon Hyuck David KwonKyung-Suk SuhJae-Won JohPublished in: Annals of surgical treatment and research (2018)
DAAs are an effective and well-tolerated treatment for HCV-infected recipients in Korea.